LARAZOTIDE+

A multi-component powder blend containing a fatty acid amide, a plant-derived flavonoid, and three peptide sequences. This material is provided in capsule format for analytical and research applications. The formulation combines compounds of interest across inflammatory, barrier, and signaling pathways for investigational purposes.

Composition (per capsule)

Palmitoylethanolamide (PEA) — 250 mg

Quercetin — 100 mg

Larazotide Acetate — 0.25 mg (250 mcg)

BPC-157 — 0.25 mg (250 mcg)

KPV (Lys-Pro-Val) — 0.25 mg (250 mcg)

Excipients: Microcrystalline Cellulose (q.s. to fill capsule), Silicon Dioxide (flow agent), Magnesium Stearate (lubricant)

General Properties

Form: Encapsulated powder blend

Appearance: Off-white to pale yellow powder (dependent on quercetin content)

Solubility: Mixed profile (lipophilic, hydrophilic, and poorly water-soluble components)

Formulation Notes

Due to the significant difference in mass between peptide components (mcg range) and bulk actives (mg range), uniform distribution requires geometric dilution and thorough blending techniques.

Intended Use

For laboratory research, analytical evaluation, and formulation development only.

Disclaimer

For Research Use Only. Not for human consumption.

Not intended to diagnose, treat, cure, or prevent any disease.